A TikToker known as (@misskofficial) explains her perspective in a direct-to-camera video, comparing feminists to Schrödinger ...

Schrödinger's stock has rebounded in recent months, despite temporary revenue recognition headwinds from the shift to hosted software. Learn more about SDGR stock here.

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Schrödinger's updated analyst framework trims its fair ...

Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. The live presentation will take ...

Schrödinger's software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world.

On November 29, 2015, cat lovers and haters will have common cause to celebrate. That date marks the 80th anniversary of the publication of Austrian physicist Erwin Schrödinger’s extraordinary paper ...

Schrödinger's growth was soft in the third quarter, and the company's losses continue to grow due to investments in internal programs. Operating expenses are expected to level out going forward, ...

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its third quarter 2023 ...

Even when labs follow ASTM and ISO standards to the letter, tensile test results for unidirectional carbon fiber composites can still vary—and the reasons why aren't always what you'd expect. A recent ...

Schrödinger Inc. shares jumped about 8% in premarket trade Monday, after the company announced a drug discovery agreement with Bristol Myers Squibb Co. that could net it up to $2.7 billion in ...

NEW YORK & SHANGHAI--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) and Viva Biotech Holdings (1873.HK) today announced a strategic collaboration to expand the reach of structure-based drug ...